Despite this success, investors were unimpressed with the topline data, with Syndax’s stock dropping by 25.6%, from $21.78 ...

BMS’ CC-97540 and Cabaletta Bio’s CABA-201 showed significant efficacy, offering new hope for severe, refractory lupus and ...

He described the autologous CAR T-cell process as, “the reprogramming of the patient's own T cells to directly attack the ...

Ensuring Product Quality with Key Process Enhancements PyroGenesis Canada is always actively exploring ways to refine HSPI's ...

This process a vibrating feeder can put crushed gold ore in a ball mill for grinding it to a finer size thereby making sure ...

Q3 2024 Earnings Call Transcript November 13, 2024 Operator: Hello and thank you for standing by. My name is Regina and will ...

Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Hello, ladies and gentlemen, and welcome to the Autolus ...

Reprioritized resources to reduce costs and enhance focus on Nana-val’s development program in relapsed or refractory EBV-positive peripheral T-cell lymphoma (PTCL ... the Company’s expectations ...

Autolus’ Aucatzyl is a B-lymphocyte antigen CD19 CAR-T cell therapy. Credit: NDAB Creativity via Shutterstock. Autolus ...

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, today reported business highlights and ...

The company’s new chief executive officer, Richard Young, said while the company expected a drop in the share price “as the ...

US-based precious metals miner i-80 Gold has announced a strategic shift following the recent appointment of Richard Young as ...